About the Company
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa (EMEA) and Australia.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on AVITA Medical, Inc.
AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Good day, and thank you for standing by. Welcome to the AVITA ...
AVITA Medical Successfully Completes Australian Equity Raise
Private placement of approximately 17.2 million new CHESS Depositary Interests (“New CDIs”) quoted on the Australian Securities Exchange (ASX)Issue price of A$1.32 per New CDI, raising approximately ...
Analysts Are More Bearish On AVITA Medical, Inc. (NASDAQ:RCEL) Than They Used To Be
NasdaqCM:RCEL 1 Year Share Price vs Fair Value Explore AVITA Medical's Fair Values from the Community and select ...
AVITA Medical, Inc. Appoints Two New Non-Executive Members to ... - Nasdaq
--AVITA Medical, Inc., a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs ...
AVITA Medical to Announce First Quarter 2024 Financial Results
AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Tuesday, May 14, 2024, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results and ...
AVITA Medical to Host Investor Webinar Briefing
Investor & Media Contact: Ben Atkins Phone +1-805 341 1571 investor@avitamedical.com media@avitamedical.com Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.
AVITA Medical, Inc. (RCEL) Q1 2024 Earnings Call Transcript
AVITA Medical, Inc. (NASDAQ: RCEL) Q1 2024 Earnings Call Transcript May 13, 2024 4:30 PM ET Company Participants Jessica Ekeberg - Director, IR James Corbett - CEO David O'Toole - CFO Conference ...
AVITA Medical, Inc. Names Michael Holder as Chief Financial Officer
--AVITA Medical, Inc., a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs ...
AVITA Medical Inc (NASDAQ:RCEL) A Bull Case Theory
We came across a bullish thesis on AVITA Medical Inc (RCEL) on ValueInvestorsClub by FT42. In this article we will summarize the bulls' thesis on RCEL.
AVITA Medical, Inc. (RCEL) Q3 2022 Earnings Call Transcript
AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ETCompany ParticipantsCaroline Corner - Managing Director, ...
AVITA Medical to Announce Second Quarter 2024 Financial Results
AVITA Medical will host a conference call and webcast that day at 1:30 p.m. Pacific Time (Friday, August 9, 2024, at 6:30 a.m. Australian Eastern Standard Time) to discuss its financial results ...
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2023 Earnings Call Transcript
AVITA Medical, Inc. misses on earnings expectations. Reported EPS is $-0.37 EPS, expectations were $-0.25. Operator: Good day and thank you for standing by. Welcome to the AVITA Medical Inc.
Similar Companies
Loading the latest forecasts...